Lineage Cell Therapeutics, Inc.: capex

Value{"amount": 116603, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"}
Period2012-01-01 – 2012-03-31
Statuscurrent
EntityLineage Cell Therapeutics, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001140361-12-024475 · Open the official SEC filing →
Retrieved: 2026-08-19T08:43:14.373961+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0000876343/capex/2012-03-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/b804d39c-afc6-45e7-b53a-b5ae6f2b272f

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies